Site models that meet patient needs at the site level.
The overriding theme in clinical development is “get medicines to the patients faster”-and to that end, many different ideas are in the mix. One of the most significant is this evolution around the patient. To get approved medicines to patients in a clinical trial, you have to find the right patients. Many of the new solutions evolving to meet this need address patients at the site level.
At the DIA Annual Meeting in June, Christian Burns, vice president of BTC Network and ClinEdge; Sean Stanton, president and CEO at LifeCore Solutions; and Jennifer Byrne, co-founder and CEO of the newly launched Javara (see: https://bit.ly/2PzGRmE) presented “Rebuilding or Building a Research Site in the Year 2020.” During the session, they presented five site models and led the audience through an interactive discussion on how each of these are evolving to meet specific challenges. The models include virtual sites; specialty practice with research extension; dedicated research sites; large multi-physician health systems with research embedded;
and academic sites. The audience discussed the pain points around each model as follows:
Specialty practice pain points
Large multi-physician practices pain points
Dedicated research site pain points
Due to the compelling topic and interest, the session didn’t have time to delve into the virtual or academic space pain points. In the table above, SCORR Marketing, our market research survey partner, and Applied Clinical Trials wanted to focus on up-and-coming organizations that are driving innovation in each of the site models. Because of space constraints, we chose one for each, but, of course, we will continue to feature these innovators in upcoming articles in our pages and online.
- Staff report
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Zerlasiran Achieves Significant Sustained Reduction in Lipoprotein(a) Levels with Infrequent Dosing
November 20th 2024Zerlasiran, a novel siRNA therapy, demonstrated over 80% sustained reductions in lipoprotein(a) levels with infrequent dosing in the Phase II ALPACAR-360 trial, highlighting its potential as a safe and effective treatment for patients at high risk of cardiovascular disease.